257 related articles for article (PubMed ID: 35399517)
41. Schlafen family is a prognostic biomarker and corresponds with immune infiltration in gastric cancer.
Xu J; Chen S; Liang J; Hao T; Wang H; Liu G; Jin X; Li H; Zhang J; Zhang C; He Y
Front Immunol; 2022; 13():922138. PubMed ID: 36090985
[TBL] [Abstract][Full Text] [Related]
42. CC chemokine receptors are prognostic indicators of gastric cancer and are associated with immune infiltration.
Liao X; Yang Y; Wang L; Kong Z; Li W
BMC Med Genomics; 2024 Jan; 17(1):1. PubMed ID: 38169378
[TBL] [Abstract][Full Text] [Related]
43. TIMM13 as a prognostic biomarker and associated with immune infiltration in skin cutaneous melanoma (SKCM).
Zhou S; Han Y; Yang R; Pi X; Li J
Front Surg; 2022; 9():990749. PubMed ID: 36061054
[TBL] [Abstract][Full Text] [Related]
44. ZNF521 Is Correlated with Tumor Immune Cell Infiltration and Act as a Valuable Prognostic Biomarker in Gastric Cancer.
Li L; Liu ZH; Wang HJ; Wang L; Ru GQ; Wang YY
Gastroenterol Res Pract; 2022; 2022():5288075. PubMed ID: 36311294
[TBL] [Abstract][Full Text] [Related]
45. Immunohistochemistry and Bioinformatics Identify GPX8 as a Potential Prognostic Biomarker and Target in Human Gastric Cancer.
Zhang X; Xu H; Zhang Y; Sun C; Li Z; Hu C; Zhao D; Guo C
Front Oncol; 2022; 12():878546. PubMed ID: 35712475
[TBL] [Abstract][Full Text] [Related]
46. SLC7A7 is a prognostic biomarker correlated with immune infiltrates in non-small cell lung cancer.
Dai W; Feng J; Hu X; Chen Y; Gu Q; Gong W; Feng T; Wu J
Cancer Cell Int; 2021 Feb; 21(1):106. PubMed ID: 33632211
[TBL] [Abstract][Full Text] [Related]
47. TMPRSS2 Serves as a Prognostic Biomarker and Correlated With Immune Infiltrates in Breast Invasive Cancer and Lung Adenocarcinoma.
Xiao X; Shan H; Niu Y; Wang P; Li D; Zhang Y; Wang J; Wu Y; Jiang H
Front Mol Biosci; 2022; 9():647826. PubMed ID: 35558557
[TBL] [Abstract][Full Text] [Related]
48. lncRNA PCBP1-AS1 mediated downregulation of ITGAL as a prognostic biomarker in lung adenocarcinoma.
Wang Q; Xiao G; Li N; Jiang X; Li C
Aging (Albany NY); 2023 May; 15(10):4510-4523. PubMed ID: 37256932
[TBL] [Abstract][Full Text] [Related]
49. Hydroxysteroid 17-Beta Dehydrogenase 6 Is a Prognostic Biomarker and Correlates with Immune Infiltrates in Hepatocellular Carcinoma.
Wu M; Jiang L
Dig Dis Sci; 2022 Jan; 67(1):146-158. PubMed ID: 33495920
[TBL] [Abstract][Full Text] [Related]
50. Increased Expression of INHBA Is Correlated With Poor Prognosis and High Immune Infiltrating Level in Breast Cancer.
Yu Z; Cheng L; Liu X; Zhang L; Cao H
Front Bioinform; 2022; 2():729902. PubMed ID: 36304286
[No Abstract] [Full Text] [Related]
51. High Endothelin Receptor Type A Expression as an Independent Prognostic Biomarker and Correlated with Immune Infiltrates in Stomach Adenocarcinoma.
Yan Y; Nie K; Zheng J; Jiang X; Huang Y; Zheng Z; Wen Y; Li P
Cancer Manag Res; 2021; 13():5013-5026. PubMed ID: 34234547
[TBL] [Abstract][Full Text] [Related]
52. TOX correlates with prognosis, immune infiltration, and T cells exhaustion in lung adenocarcinoma.
Guo L; Li X; Liu R; Chen Y; Ren C; Du S
Cancer Med; 2020 Sep; 9(18):6694-6709. PubMed ID: 32700817
[TBL] [Abstract][Full Text] [Related]
53. YTHDF1 Is a Potential Pan-Cancer Biomarker for Prognosis and Immunotherapy.
Hu J; Qiu D; Yu A; Hu J; Deng H; Li H; Yi Z; Chen J; Zu X
Front Oncol; 2021; 11():607224. PubMed ID: 34026603
[TBL] [Abstract][Full Text] [Related]
54. CLEC11A expression as a prognostic biomarker in correlation to immune cells of gastric cancer.
Fang W; Wan D; Yu Y; Zhang L
Biomol Biomed; 2024 Jan; 24(1):101-124. PubMed ID: 37597212
[TBL] [Abstract][Full Text] [Related]
55. Comprehensive Analysis of Prognostic Value of MEX3A and Its Relationship with Immune Infiltrates in Ovarian Cancer.
Zhang P; Su T; Zhang S
J Immunol Res; 2021; 2021():5574176. PubMed ID: 34189143
[TBL] [Abstract][Full Text] [Related]
56. DOCK4 as a Potential Biomarker Associated with Immune Infiltration in Stomach Adenocarcinoma: A Database Analysis.
Lu Y; Yu J; Dong Q; Du Y; Liang Z
Int J Gen Med; 2022; 15():6127-6143. PubMed ID: 35846794
[TBL] [Abstract][Full Text] [Related]
57. LCP1 is a prognostic biomarker correlated with immune infiltrates in gastric cancer.
Zeng Q; Li L; Feng Z; Luo L; Xiong J; Jie Z; Cao Y; Li Z
Cancer Biomark; 2021; 30(1):105-125. PubMed ID: 32986657
[TBL] [Abstract][Full Text] [Related]
58. CCL14 is a prognostic biomarker and correlates with immune infiltrates in hepatocellular carcinoma.
Gu Y; Li X; Bi Y; Zheng Y; Wang J; Li X; Huang Z; Chen L; Huang Y; Huang Y
Aging (Albany NY); 2020 Jan; 12(1):784-807. PubMed ID: 31927532
[TBL] [Abstract][Full Text] [Related]
59. AGT May Serve as a Prognostic Biomarker and Correlated with Immune Infiltration in Gastric Cancer.
Wu F; Zhang L; Wang L; Zhang D
Int J Gen Med; 2022; 15():1865-1878. PubMed ID: 35264871
[TBL] [Abstract][Full Text] [Related]
60. m
Yu Y; Meng LL; Chen XY; Fan HN; Chen M; Zhang J; Zhu JS
Cell Signal; 2023 Aug; 108():110699. PubMed ID: 37149073
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]